$25.73
-1.27-4.7%
Last update: Nov 6, 1:42 PM
Arcutis Biotherapeutics Inc
ARQTNASDAQ
The average analyst price target for Arcutis Biotherapeutics is $34.20, 32.9% above the current price. Of 10 analysts, 8 rate it Buy and 2 Hold. Targets range from $15 to $48. The latest change came on Nov 5, 2026, when TD Cowen raised its price target on Arcutis Biotherapeutics from $35 to $40 and kept a Buy rating.
Price Target Range — 13 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
